Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties

60Citations
Citations of this article
63Readers
Mendeley users who have this article in their library.

Abstract

Optimization of the current dendritic cell (DC) culture protocol in order to promote the therapeutic efficacy of DC-based immunotherapy is warranted. Alternative differentiation of monocyte-derived DCs using granulocyte macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-15 has been propagated as an attractive strategy in that regard. The applicability of these so-called IL-15 DCs has not yet been firmly established. We therefore developed a novel pre-clinical approach for the generation of IL-15 DCs with potent immunostimulatory properties.

Cite

CITATION STYLE

APA

Anguille, S., Smits, E. L. J. M., Cools, N., Goossens, H., Berneman, Z. N., & Van Tendeloo, V. F. I. (2009). Short-term cultured, interleukin-15 differentiated dendritic cells have potent immunostimulatory properties. Journal of Translational Medicine, 7. https://doi.org/10.1186/1479-5876-7-109

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free